Latest filing published 15 Jul 2026 for Nuvalent, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Christopher Durant Turner on record concern Nuvalent, Inc., in the capacity of senior executive. In total, 12 filings cover trades dated from 17 May 2022 to 15 July 2026.
Sales make up the whole of the open-market record (1 sale, €71k). Other entries cover 3 share grants and 5 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
Most recently, on 15 July 2026, the filings show a share grant in Nuvalent, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations